Dassault Systèmes to buy ArisGlobal for $1.8 billion to build AI‑driven drug platform
AI-generated summary Dassault Systèmes announced it will acquire ArisGlobal for $1.8 billion in cash to build an artificial intelligence-driven drug platform. The purchase includes an additional contingent payment of up to $200 million tied to artificial intelligence-related revenue targets.